The opening of the center was held: patients with Still's disease will participate in a phase 3 multicenter study to evaluate the efficacy and safety of GNR-086 compared with Ilaris®, sponsored by GENERIUM Pharmaceutical Company, Russia.
We invite patients with mild bronchial asthma to participate in the study of the treatment of asthma of physical effort. During each of the four visits to the study site, a physical exercise test and a series of studies of the function of external respiration will be conducted.
OLLA-MED LLC celebrates the anniversary date – five years since the foundation of the Clinical Trials Department. There are more than 40 successfully conducted protocols, hundreds of treated patients and successfully completed audits. We hope that a successful start will be the key to new victories and achievements. Happy anniversary!
Our site has been selected to participate in the study of a new medicine for the treatment of fungal nail lesions. Patients will be monitored for about a year and will receive not only the most modern treatment, but also regular medical pedicure.
